A Study of MEDI5395 in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors


Study Number
82519
Phase
I
Purpose

The reason for the study is to find out if MEDI5395 and durvalumab will work and be safe for the treatment of solid tumors.

Full Title

An Open-label Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MEDI5395 in Combination with Durvalumab in Subjects with Select Advanced Solid Tumors

ClinicalTrials.Gov ID
NCT03889275

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.